1. The Controversy Regarding Margin Width in Breast Cancer: Enough is Enough

   • Kelly K. Hunt
   • Benjamin D. Smith
   • Elizabeth A. Mittendorf

   Breast Oncology 29 January 2014 Pages: 701 - 703

2. Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer

   • Meena S. Moran
   • Stuart J. Schnitt
   • Monica Morrow

   Breast Oncology – Special Article 10 February 2014 Pages: 704 - 716

   

3. The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis

   • Nehmat Houssami
   • Petra Macaskill
   • Monica Morrow

   Breast Oncology 29 January 2014 Pages: 717 - 730

   

4. Follow-Up After Curative Cancer Surgery: Understanding Costs and Benefits

   • Bridget N. Fahy

   Healthcare Policy and Outcomes 27 December 2013 Pages: 731 - 732

5. Intensity of Follow-Up After Breast Cancer Surgery: Low Versus High?

   • Julie A. Margenthaler
   • Frank E. Johnson
   • Amy E. Cyr

   Breast Oncology 18 September 2013 Pages: 733 - 737

6. Follow-up After Curative Resection of Colorectal Cancer

   • Bridget N. Fahy

   Colorectal Cancer 22 November 2013 Pages: 738 - 746

7. Intensity of Follow-up after Pancreatic Cancer Resection

   • Jason A. Castellanos
   • Nipun B. Merchant

   Pancreatic Tumors 04 October 2013 Pages: 747 - 751

8. Intensity of Follow-Up After Melanoma Surgery

   • Christopher P. Scally
   • Sandra L. Wong

   Melanomas 10 October 2013 Pages: 752 - 757

9. Treatment Options and Surveillance Strategies After Therapy for Hepatocellular Carcinoma

   • Ioannis Hatzaras
   • Danielle A. Bischof
   • Timothy M. Pawlik

   Hepatobiliary Tumors 05 September 2013 Pages: 758 - 766

   

10. A Cost-Utility Analysis for Prophylactic Central Neck Dissection in Clinically Nodal-Negative Papillary Thyroid Carcinoma

    • Carlos K. H. Wong
    • Brian Hung-Hin Lang

    Endocrine Tumors 26 November 2013 Pages: 767 - 777

    

11. Elevated Preoperative Systemic Inflammatory Markers Predict Poor Outcome in Localized Soft Tissue Sarcoma

    • Eun-Seok Choi
    • Han-Soo Kim
    • Ilkyu Han

    Bone and Soft Tissue Sarcomas 04 December 2013 Pages: 778 - 785

    

12. Breast-Conserving Surgery With or Without Radiotherapy in Older Breast Patients With Early Stage Breast Cancer: A Systematic Review and Meta-analysis

    • Willemien van de Water
    • Esther Bastiaannet
    • Gerrit-Jan Liefers

    Breast Oncology 23 November 2013 Pages: 786 - 794

    

13. Reducing Persistent Postoperative Pain and Disability 1 Year After Breast Cancer Surgery: A Randomized, Controlled Trial Comparing Thoracic Paravertebral Block to Local Anesthetic Infiltration

    • Michelle Chiu
    • Gregory L. Bryson
    • Howard J. Nathan

    Breast Oncology Open access 29 October 2013 Pages: 795 - 801

    

14. Quilting Prevents Seroma Formation Following Breast Cancer Surgery: Closing the Dead Space by Quilting Prevents Seroma Following Axillary Lymph Node Dissection and Mastectomy

    • Britt ten Wolde
    • Frits J. H. van den Wildenberg
    • Luc J. A. Strobbe

    Breast Oncology 12 November 2013 Pages: 802 - 807

    

15. Harmonic Scalpel Versus Electrocautery Dissection in Modified Radical Mastectomy: A Randomized Controlled Trial

    • Salma Khan
    • Shaista Khan
    • Ghulam Murtaza

    Breast Oncology 14 November 2013 Pages: 808 - 814

    

16. Treatment of Extensive Metastatic Colorectal Cancer to the Liver with Systemic and Hepatic Arterial Infusion Chemotherapy and Two-Stage Hepatic Resection: The Role of Salvage Therapy for Recurrent Disease

    • Kenneth Cardona
    • Dino Donataccio
    • Michael I. D’Angelica

    Colorectal Cancer 18 November 2013 Pages: 815 - 821

    

17. An MRI-based Assessment of Standard and Extralevator Abdominoperineal Excision Specimens: Time for a Patient Tailored Approach?

    • Peter How
    • Nicholas P. West
    • G. Brown

    Colorectal Cancer 23 November 2013 Pages: 822 - 828

    

18. Attaining Surgical Competency and Its Implications in Surgical Clinical Trial Design: A Systematic Review of the Learning Curve in Laparoscopic and Robot-Assisted Laparoscopic Colorectal Cancer Surgery

    • Jenifer Barrie
    • David G. Jayne
    • Sue H. Pavitt

    Colorectal Cancer 12 November 2013 Pages: 829 - 840

    

19. Suprapubic Single-Incision Laparoscopic Left Hemicolectomy: An Alternative Non-Visible Scar

    • Giovanni Dapri

    Original Article – Colorectal Cancer 24 December 2013 Pages: 841 - 842

20. Risk of Thyroid Cancer in Patients with Thyroiditis: A Population-Based Cohort Study

    • Chien-Liang Liu
    • Shih-Ping Cheng
    • Yuen-Liang Lai

    Endocrine Tumors 08 November 2013 Pages: 843 - 849

    

21. A Systematic Review and Meta-analysis Comparing Surgically-Related Complications between Robotic-Assisted Thyroidectomy and Conventional Open Thyroidectomy

    • Brian Hung-Hin Lang
    • Carlos K. H. Wong
    • Koon Yat Wan

    Endocrine Tumors 23 November 2013 Pages: 850 - 861

    

22. The Addition of Radiation to Chemotherapy does not Improve Outcome When Compared to Chemotherapy in the Treatment of Resected Pancreas Cancer: The Results of a Single-Institution Experience

    • Ludmila Katherine Martin
    • Dai Chu Luu
    • Tanios Bekaii-Saab

    Gastrointestinal Oncology 18 September 2013 Pages: 862 - 867

    

23. Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

    • Konstantinos I. Votanopoulos
    • Reese W. Randle
    • Majid Mirzazadeh

    Gastrointestinal Oncology 12 November 2013 Pages: 868 - 874

    

24. A Comparison of Five Competing Lymph Node Staging Schemes in a Cohort of Resectable Gastric Cancer Patients

    • David D. Smith
    • Rebecca A. Nelson
    • Roderich E. Schwarz

    Gastrointestinal Oncology 18 November 2013 Pages: 875 - 882

    

25. Morbidity Associated with Colostomy Reversal After Cytoreductive Surgery and HIPEC

    • Erienne M. V. de Cuba
    • Victor J. Verwaal
    • Elisabeth A. te Velde

    Gastrointestinal Oncology 18 November 2013 Pages: 883 - 890

    

26. Prognostic Significance of Complications after Curative Surgery for Gastric Cancer

    • Takeshi Kubota
    • Naoki Hiki
    • Toshiharu Yamaguchi

    Gastrointestinal Oncology 20 November 2013 Pages: 891 - 898

    

27. Anatomic Extent of Metastatic Lymph Nodes: Still Important for Gastric Cancer Prognosis

    • Taeil Son
    • Woo Jin Hyung
    • Sung Hoon Noh

    Gastrointestinal Oncology 26 November 2013 Pages: 899 - 907

    

28. Melphalan: A Promising Agent in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Armando Sardi
    • William Jimenez
    • Vadim Gushchin

    Gastrointestinal Oncology 26 November 2013 Pages: 908 - 914

    

29. A Multifactorial Histopathologic Score for the Prediction of Prognosis of Resected Esophageal Adenocarcinomas After Neoadjuvant Chemotherapy

    • Rupert Langer
    • Karen Becker
    • Katja Ott

    Gastrointestinal Oncology 27 November 2013 Pages: 915 - 921

    

30. Assessment of Short-Term Clinical Outcomes following Salvage Esophagectomy for the Treatment of Esophageal Malignancy: Systematic Review and Pooled Analysis

    • Sheraz R. Markar
    • Alan Karthikesalingam
    • Donald E. Low

    Gastrointestinal Oncology 09 November 2013 Pages: 922 - 931

    

31. T1 Squamous Cell Carcinoma of the Esophagus: Long-Term Outcomes and Prognostic Factors After Esophagectomy

    • Toshiaki Tanaka
    • Satoru Matono
    • Hiromasa Fujita

    Thoracic Oncology 15 November 2013 Pages: 932 - 938

    

32. Association of a Genetic Variant of CYP19A1 with Multicentric Development of Lung Adenocarcinomas

    • Koei Ikeda
    • Kenji Shiraishi
    • Makoto Suzuki

    Thoracic Oncology 18 November 2013 Pages: 939 - 945

    

33. EGFR, BRAF and KRAS Status in Patients Undergoing Pulmonary Metastasectomy from Primary Colorectal Carcinoma: A Prospective Follow-Up Study

    • Thomas Schweiger
    • Balazs Hegedüs
    • Konrad Hoetzenecker

    Thoracic Oncology 27 November 2013 Pages: 946 - 954

    

34. HE4 Expression in Plasma Correlates with Surgical Outcome and Overall Survival in Patients with First Ovarian Cancer Relapse

    • Elena Ioana Braicu
    • Radoslav Chekerov
    • Klaus Pietzner

    Gynecologic Oncology 12 November 2013 Pages: 955 - 962

    

35. Relation Between Age, Comorbidity, and Complications in Patients Undergoing Major Surgery for Head and Neck Cancer

    • Thomas T. A. Peters
    • Boukje A. C. van Dijk
    • Gyorgy B. Halmos

    Head and Neck Oncology 19 November 2013 Pages: 963 - 970

    

36. Long-Term Outcomes and Prognostic Factors with Reductive Hepatectomy and Sequential Percutaneous Isolated Hepatic Perfusion for Multiple Bilobar Hepatocellular Carcinoma

    • Takumi Fukumoto
    • Masahiro Tominaga
    • Yonson Ku

    Hepatobiliary Tumors 08 November 2013 Pages: 971 - 978

    

37. Prognostic Significance of the Highest Peripancreatic Lymph Node in Biliary Tract Adenocarcinoma

    • Kaitlyn J. Kelly
    • Katerina Dukleska
    • Yuman Fong

    Hepatobiliary Tumors 09 November 2013 Pages: 979 - 985

    

38. Assessing Prognostic Significance of Preoperative Alpha-Fetoprotein in Hepatitis B-Associated Hepatocellular Carcinoma: Normal is not the New Normal

    • Sima Blank
    • Qin Wang
    • Spiros P. Hiotis

    Hepatobiliary Tumors 14 November 2013 Pages: 986 - 994

    

39. Morbidity and Mortality in 1,174 Patients Undergoing Hepatic Parenchymal Transection Using a Stapler Device

    • Mustafa Raoof
    • Thomas A. Aloia
    • Steven A. Curley

    Hepatobiliary Tumors 19 November 2013 Pages: 995 - 1001

40. The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma

    • Shuji Sumie
    • Osamu Nakashima
    • Michio Sata

    Hepatobiliary Tumors 20 November 2013 Pages: 1002 - 1009

    

41. Does Anti-HBV Therapy Benefit the Prognosis of HBV-Related Hepatocellular Carcinoma Following Hepatectomy?

    • Liang-He Yu
    • Nan Li
    • Shu-Qun Cheng

    Hepatobiliary Tumors 12 October 2013 Pages: 1010 - 1015

42. Prognosis of Patients with Melanoma and Microsatellitosis Undergoing Sentinel Lymph Node Biopsy

    • Edmund K. Bartlett
    • Meera Gupta
    • Giorgos C. Karakousis

    Melanomas 21 November 2013 Pages: 1016 - 1023

    

43. Src Family Kinase Inhibition as a Novel Strategy to Augment Melphalan-Based Regional Chemotherapy of Advanced Extremity Melanoma

    • Yoshihiro Tokuhisa
    • Michael E. Lidsky
    • Douglas S. Tyler

    Melanomas 27 November 2013 Pages: 1024 - 1030

    

44. Tumor-Associated Macrophages Promote Oral Cancer Progression Through Activation of the Axl Signaling Pathway

    • Chien-Hsing Lee
    • Shyun-Yeu Liu
    • Yi-Shing Shieh

    Translational Research and Biomarkers 26 November 2013 Pages: 1031 - 1037

    

45. Metastatic Behavior of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: Association with Primary Tumor Location

    • Nobuyuki Tanaka
    • Eiji Kikuchi
    • Mototsugu Oya

    Urologic Oncology 12 November 2013 Pages: 1038 - 1045

46. MicroRNAs with Prognostic Potential for Metastasis in Clear Cell Renal Cell Carcinoma: A Comparison of Primary Tumors and Distant Metastases

    • Joana Heinzelmann
    • André Unrein
    • Kerstin Junker

    Urologic Oncology 18 November 2013 Pages: 1046 - 1054